ArticleRisk management and healthcare policy2025
Retrospective Cohort Study: Nomogram for 1-Year in-Stent Restenosis After PCI in Coronary Heart Disease.
Article in Risk management and healthcare policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct a nomogram for risk prediction of in-stent restenosis (ISR) within one year after percutaneous coronary intervention (PCI) for coronary heart disease (CHD). Methods: This study included 842 patients with severe CHD who underwent PCI at Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine between March 2016 to March 2024. Based on the occurrence of ISR within one year post-PCI, patients were stratified into two groups: the ISR group (n=112) and the non-ISR group (n=730). Potential risk factors were initially identified using LASSO regression, followed by multivariate logistic regression to determine independent predictors. A nomogram prediction model was developed using R software (version 4.2.6) and internally validated via the bootstrap resampling method (1000 iterations). Model performance was assessed through receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis (DCA). Results: This analysis revealed seven risk factors for ISR: diabetes (OR=1.380, 95% CI: 1.090-1.747), neutrophil/lymphocyte ratio (NLR, OR=2.312, 95% CI: 1.830-2.922), low-density lipoprotein (LDL) > 1.8 mmol/L (OR=2.159, 95% CI: 1.080-4.315), calcified lesions (OR=3.780, 95% CI: 2.051-6.968), stent diameter <3 mm (OR=2.595, 95% CI: 1.404-4.796), smoking (OR=2.796, 95% CI: 1.511-5.174) and no intravascular ultrasound (IVUS) assisted (OR=2.176, 95% CI: 1.342~3.257). These seven factors were incorporated into the nomogram model. The model demonstrated excellent discriminative ability, with an area under the curve (AUC) of 0.892 (95% CI: 0.859-0.924) and a consistency index (C-index) of 0.923. Calibration analysis showed close agreement between predicted and observed outcomes, while DCA indicated strong clinical utility across a wide probability threshold range (5.0%-86.2%). The relative importance of the risk factors, ranked in descending order, was as follows: calcified lesions, stent diameter <3 mm, no IVUS assisted, LDL>1.8 mmol/L, smoking, NLR and diabetes. Conclusion: The study identifies several risk factors for ISR in CHD patients within one year after PCI. The constructed nomogram model has good predictive efficiency and clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.